Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome

Overview of attention for article published in Eye, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
policy: 2 policy sources

twitter: 5 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 116 Dimensions

Readers on

mendeley: 132 Mendeley

Summary News Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Brolucizumab for treating wet age-related macular degeneration : Committee papers

Cited by National Institute for Health and Care Excellence on 18 Dec 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 30 Jul 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Preventing avoidable sight loss

Cited by UK Parliament Briefing notes on 24 Mar 2017

The UK Parliament is the supreme legislative body in the United Kingdom, British Crown dependencies and British overseas territories. It possesses legislative supremacy and thereby ultimate power over all other political bodies in the UK and its territories.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.